Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Total 13F shares
-
14,457,812
-
Share change
-
+539,793
-
Total reported value
-
$137,523,752
-
Price per share
-
$9.51
-
Number of holders
-
68
-
Value change
-
+$2,034,702
-
Number of buys
-
20
-
Number of sells
-
40
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q4 2021
As of 31 Dec 2021,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,457,812 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., CREDIT SUISSE AG/, Harel Insurance Investments & Financial Services Ltd., GREAT POINT PARTNERS LLC, RTW INVESTMENTS, LP, Horton Capital Management, LLC, Migdal Insurance & Financial Holdings Ltd., ZEKE CAPITAL ADVISORS, LLC, and Wildcat Capital Management, LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.